Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
Recruiting now
Conditions studied: Prostate Cancer
In brief
This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Key facts
- Study ID
- NCT06785441
- Run by
- M.D. Anderson Cancer Center
- People needed
- 180
- Starts
- 2023-05-25
- Expected to finish
- 2030-02-02
- Last updated by the study team
- 2025-02-04
Who can join
Age: 65 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patients:
- Males aged 65 or older
- Diagnosis of localized prostate cancer
- Have not received curative intent treatment for their prostate cancer
- Fluent in English
- Care partners/caregivers:
- Aged 18 or older
- Fluent in English
- Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)
You may not qualify if…
- Patients
- Currently receiving treatment for another cancer (primary or recurrence)
- Care partners/caregivers
- None
Where it is running
- M.D. Anderson Cancer Center — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.